CN Rathcke, F Persson, L Tarnow, P Rossing, … - Diabetes care, 2009 - Am Diabetes Assoc RESULTS—Median levels [interquartile range] of serum YKL-40 were significantly
higher in normoalbuminuria versus control (37 [29–52] vs. 53 [32–105] ng/ml,
P < 0.01) and were increasing with increasing levels of albuminuria ( ... Cited by 3 - Related articles - All 5 versions
CN Rathcke, I Raymond, C Kistorp, P … - International Journal of Cardiology, 2009 - Elsevier In subjects without diabetes and CVD at baseline, increasing YKL-40 levels
independently predicted overall and CV mortality rate with hazard ratios of 1.58
(95% confidence interval (CI), 1.12–2.23, p = 0.009) and 1.57 (95% CI, ... Cited by 2 - Related articles - All 2 versions
- ►diabetesjournals.org AR Nielsen, C Erikstrup, JS Johansen, CP … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Patients with type 2 diabetes had higher plasma YKL-40 (76.7 vs. 45.1
ng/ml, P = 0.0001) but not higher expression in adipose tissue YKL-40 mRNA (1.20
vs. 0.98, P = 0.2) compared with subjects with a normal glucose tolerance. ... Cited by 3 - Related articles - All 3 versions
C Nøjgaard, NB Høst, IJ Christensen, SH … - Coronary artery disease, 2008 - journals.lww.com Objectives YKL-40 is secreted by macrophages, including those in atherosclerotic
plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is
elevated in patients with inflammation and increased tissue remodeling. The ... Cited by 11 - Related articles - BL Direct - All 7 versions
Y Wang, RS Ripa, JS Johansen, A Gabrielsen, … - Scandinavian Cardiovascular Journal, 2008 - informahealthcare.com Background. YKL-40 is involved in remodelling and angiogenesis in non-cardiac
inflammatory diseases. Aim was to quantitate plasma YKL-40 in patients with
ST-elevation myocardial infarction (STEMI) or stable chronic coronary ... Cited by 5 - Related articles - All 5 versions
A Roslind, AS Knoop, MB Jensen, JS Johansen … - Breast Cancer Research and Treatment, 2008 - Springer Abstract YKL-40 is a new biomarker in serum with a prognostic value in several
localized and metastatic malignancies. The current knowledge regarding the bio-
logical functions of YKL-40 in cancer links YKL-40 to increased ... Cited by 5 - Related articles - All 2 versions
- ►jimmunol.org S Letuve, A Kozhich, N Arouche, M … - The Journal of Immunology, 2008 - Am Assoc Immnol YKL-40 is a chitin-binding protein that is elevated in patients with various
inflammatory conditions associated with ongoing remodeling. We investigated
whether the levels of YKL-40 were up-regulated in the circulation and the ... Cited by 6 - Related articles - All 2 versions
M Kucur, FK Isman, B Karadag, VA Vural, S … - Coronary artery disease, 2007 - journals.lww.com Atherosclerosis is considered to be an inflammatory disease in which the initial
process is the augmented infiltration of monocytes into the vessel wall and
their subsequent differentiation from macrophages into lipid-laden foam ... Cited by 15 - Related articles - BL Direct - All 6 versions
A Kruit, JC Grutters, HJT Ruven, CCM van … - Respiratory Medicine, 2007 - Elsevier Patients had significantly higher (mean, 95% CI) serum YKL-40 levels (181.3
ng/ml, 50.7–648.1) compared to controls (36.6 ng/ml, p<0.0001. Serum YKL-40
was elevated in 79% of the patients and was inversely correlated with DLco ... Cited by 7 - Related articles - All 13 versions
DM Lebensztejn… - 7 Reflections on the future of gastroenterology–unmet …, 2007 - advms.pl 120 Lebensztejn DM, et al.· Advances in Medical Sciences· Vol. 52· 2007·
Abstract Purpose: The aim of the study was to evaluate the serum concentration
of YKL-40 (human cartilage glycoprotein-39) in the assessment of fibrosis ... Cited by 2 - Related articles - View as HTML - All 3 versions
